Evidence map›Paper›PMID 41327100›Full record

ArticleBMC geriatrics2025

Predictive model development for possible sarcopenia in community-dwelling older adults: a cross-sectional machine learning approach using the Korean frailty and aging cohort study.

Sooyoung Kwon, Layoung Kim, Chang Won Won, Namhee Kim, Jae Young Chang, Miji Kim, Gwang Suk Kim

Abstract read
In one paragraph

Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sooyoung KwonCollege of Nursing, Yonsei University, Seoul, Republic of Korea.
Layoung KimDepartment of Nursing, The University of Suwon, Hwaseong, Republic of Korea.
Chang Won WonElderly Frailty Research Center, Department of Family Medicine, College of Medicine, Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Namhee KimWonju College of Nursing, Yonsei University, Wonju, Gangwon-do, Republic of Korea.
Jae Young ChangDepartment of Health Sciences and Technology, College of Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Miji Kim *Department of Health Sciences and Technology, College of Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea. mijiak@khu.ac.kr.ORCID http://orcid.org/0000-0002-0852-8825
Gwang Suk Kim *Mo-Im Kim Nursing Research Institute, College of Nursing, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. gskim@yuhs.ac.ORCID https://orcid.org/0000-0001-9823-6107

Funding

the 2023 Faculty-Student Research Fund provided by the Mo-Im Kim Nursing Research Institute, College of Nursing, Yonsei University 6-2023-0187the Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) RS-2024-00353845the National Institute of Health research project 2021-ER0605-01, 2021-ER0605-02the NRF grant funded by the Ministry of Education RS-2020-NR049581
6 · The paper itself

Abstract

backgroundSarcopenia, an age-related decline in muscle mass and physical function, is a major risk factor for frailty, a condition associated with negative health outcomes and increased disease burden in older adults. Providing simple, accurate community-based screening is essential for early prevention and improving the health and quality of life of older adults. Employing screening criteria for possible sarcopenia can broadly identify individuals at risk for sarcopenia and enhance early diagnosis and preventive measures. However, there is a lack of possible sarcopenia prediction models. This study developed and evaluated a model for predicting possible sarcopenia among community-dwelling older adults and identified key predictors.

methodsA supervised machine learning approach was used, with data from the 2022-2023 Korean Frailty and Aging Cohort Study (n = 1,761). Individuals were classified as having possible or no possible sarcopenia based on the 2019 Asian Working Group for Sarcopenia criteria. Logistic regression, random forest, support vector machine, and extreme gradient boosting machine learning models were developed, and their predictive performance was assessed using accuracy, precision, recall, F1-score, and receiver operating characteristic curve-area under the curve. Feature importance was analysed applying Shapley additive explanations.

resultsThe final sample comprised 500 individuals with possible sarcopenia (mean age: 83.0 ± 3.76 years; 34.4% men) and 1,261 without possible sarcopenia (mean age: 81.0 ± 3.40 years, 51.6% men). Logistic regression demonstrated the best predictive performance among the four models, with the highest recall of 0.700 and F1-score of 0.654. The most influential predictors for possible sarcopenia were lower body mass index, walking aid use, cognitive impairment, older age, and exhaustion.

conclusionsMultidomain geriatric indicators including anthropometric status (body mass index), walking aid use, cognitive function, age, and exhaustion can guide pragmatic, community-based screening for possible sarcopenia. Simple, accessible assessments of these predictors may facilitate earlier identification and referral, and should be considered in sarcopenia screening and prevention strategies. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

AgingFrailtyGeriatric AssessmentIndependent LivingMachine LearningSarcopeniaAgedAged, 80 and overCohort StudiesCross-Sectional StudiesFemaleHumansMaleRepublic of KoreaAgedBody mass indexCognitive impairmentCommunity-dwellingMachine learningPossible sarcopenia

Identifiers

PMID41327100
PMCPMC12667061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.